There is worldwide concern for lack of specific therapy against the novel Betacoronavirus
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This case report presents …

Use of Hydroxychloroquine in Patients with COVID-19: A Retrospective Observational Study -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

BACKGROUND: Hydroxychloroquine and chloroquine have been proposed as treatments
for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from …

The COVID-19 pandemic is showing an exponential growth, mandating an urgent need to
develop an effective treatment. Indeed, to date, a well-established therapy is still lacking. We …

Background Hydroxychloroquine and chloroquine have been proposed as treatments for
coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from …

During the Covid-19 pandemic, many intensive care unit (ICU) patients received
hydroxychloroquine. The primary objective of this study was to assess the effects of …

Chloroquine (CQ) and its derivatives such as hydroxychloroquine (HCQ) remain mainstay of
therapy for malaria. These drugs are also approved for certain autoimmune diseases …

Introduction Hydroxychloroquine (HCQ) is an antimalarial drug that received worldwide
news and media attention in the treatment of patients with coronavirus disease 2019 (COVID …

Coronavirus disease 2019 (COVID-19), which is caused by a novel severe acute respiratory
syndrome coronavirus (SARS-CoV-2), has recently emerged as a global health threat. To …

Introduction The novel coronavirus pandemic (COVID–19) represents a major public health
problem and it is key to find a treatment that reduces mortality. Our objective was to estimate …